Aussie Report Urges Greater TGA Control Over Psychiatric Drugs
This article was originally published in PharmAsia News
Executive Summary
An Australian report urges the nation's drug regulator to step up warning labels on psychiatric drugs as it supervises research and exerts greater control in introducing drugs for mass consumption